TLR4 and neoplasm: Conversely, the CB2 cannabinoid receptor has been shown to inhibit TLR4 signaling and promote fatty acid oxidation, and pharmacological antagonism of this receptor reduced tumor growth independently of CB2 expression in tumor cells (266).